Direct oral anticoagulants versus Vitamin K antagonist in kidney transplant recipients with atrial fibrillation: A study from a global federated research network
In this real-world cohort of KTRs with AF, DOACs use was associated with lower risk of the composite outcome and kidney transplant rejection.
Authors
- Muath Alobaida (ORCID: https://orcid.org/0000-0003-1257-1428)
- Amir Askarinejad (ORCID: https://orcid.org/0000-0003-2803-079X)
- Enrico Tartaglia (ORCID: https://orcid.org/0009-0006-7655-8651)
- Louise Oni
- Claudio Ferri
- Michele Rossi
- Gregory Y.H. Lip
- Tommaso Bucci
- Andrea Galeazzo Rigutini
- Anirudh Rao
Institutions
- University of Liverpool (GB)
- University of L'Aquila (IT)
- Great Ormond Street Hospital for Children NHS Foundation Trust (GB)
- Liverpool Heart and Chest Hospital (GB)
- San Salvatore Hospital (IT)
- University College London (GB)
- Liverpool John Moores University (GB)
Publication Details
- Journal
- European Journal of Internal Medicine
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.ejim.2026.106751
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 60.13